Dollars for Docs

How Industry Dollars Reach Your Doctors

XTANDI
drug

XTANDI

Treats metastatic prostate cancer.
Cash
$13.2M

payments related to this drug

Doctor
14,741

doctors receiving payments

Company
6

companies making payments related to this drug

Drug
12%

of payments for this drug were also associated with another product

Companies Making Payments Related to this Drug

Aggregate totals are shown, including payments to doctors and teaching hospitals. To purchase bulk data, please visit the ProPublica Data Store.

Company Payment
ASTELLAS PHARMA US INC $6.47M
MEDIVATION INC. $5.52M
ASTELLAS PHARMA GLOBAL DEVELOPMENT $539K
ASTELLAS SCIENTIFIC AND MEDICAL AFFAIRS $518K
ASTELLAS PHARMA INC $98,064
ASTELLAS PHARMA EUROPE BV $10,216

Top Doctors Receiving Payments Related to this Drug

Totals listed account for all payments from August 2013 to December 2016.

Doctor Location Money Paid
ELIOPOULOS
HELEN ELIOPOULOS

GLENVIEW, IL

$348K
KASSABIAN
VAHAN KASSABIAN

MARIETTA, GA

$328K
AMATO
ROBERT AMATO

HOUSTON, TX

$312K
CONCEPCION
RAOUL CONCEPCION

NASHVILLE, TN

$268K
KOCHHAR
RUBY KOCHHAR

HAMPTON, VA

$264K
FABRIZIO
MICHAEL FABRIZIO

VIRGINIA BEACH, VA

$237K
TWARDOWSKI
PRZEMYSLAW TWARDOWSKI

DURATE, CA

$209K
VAISHAMPAYAN
ULKA VAISHAMPAYAN

DETROIT, MI

$202K
MEGA
ANTHONY MEGA

PROVIDENCE, RI

$194K
SILBERSTEIN
JONATHAN SILBERSTEIN

NEW ORLEANS, LA

$185K

Top Teaching Hospitals Receiving Payments Related to this Drug

Note: We have made some effort to normalize the data and eliminate duplicates, but data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].